Compare ARVN & UVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARVN | UVE |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 925.9M |
| IPO Year | 2018 | 1992 |
| Metric | ARVN | UVE |
|---|---|---|
| Price | $12.24 | $29.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 1 |
| Target Price | $18.14 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 792.5K | 206.0K |
| Earning Date | 02-10-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 2.57% |
| EPS Growth | N/A | ★ 70.32 |
| EPS | N/A | ★ 4.23 |
| Revenue | $312,300,000.00 | ★ $1,580,798,000.00 |
| Revenue This Year | $11.17 | $1.87 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.07 |
| Revenue Growth | ★ 93.86 | 4.61 |
| 52 Week Low | $5.90 | $18.92 |
| 52 Week High | $20.38 | $35.84 |
| Indicator | ARVN | UVE |
|---|---|---|
| Relative Strength Index (RSI) | 53.70 | 38.83 |
| Support Level | $11.88 | $29.48 |
| Resistance Level | $12.79 | $31.25 |
| Average True Range (ATR) | 0.53 | 1.09 |
| MACD | 0.01 | -0.30 |
| Stochastic Oscillator | 68.02 | 15.35 |
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums, earned net interest and dividend income from the investment portfolio, the collection of reinsurance recoverable and financing fees. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.